Forschung & Innovation
Publikationen
S2k Guidelines for Cutaneous Basal Cell Carcinoma - Part 2: Treatment, Prevention and Follow-up
PMU Autor*innen
L. M. Heindl, M. P. Schön, R. Kaufmann
Alle Autor*innen
B. M. Lang, P. Balermpas, A. Bauer, A. Blum, G. F. Brölsch, T. Dirschka, M. Follmann, J. Frank, B. Frerich, K. Fritz, A. Hauschild, L. M. Heindl, H. P. Howaldt, S. Ihrler, V. Kakkassery, B. Klumpp, A. Krause-Bergmann, C. Löser, M. Meissner, M. M. Sachse, M. Schlaak, M. P. Schön, L. Tischendorf, M. Tronnier, D. Vordermark, J. Welzel, M. Weichenthal, S. Wiegand, R. Kaufmann, S. Grabbe
Fachzeitschrift
JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT
Kurzfassung
Basal cell carcinoma (BCC) is the most common malignant tumor among fair-skinned individuals, and its incidence had been steadily rising in the past decades. In order to maintain the highest quality of patient care possible, the German S2k guidelines were updated following a systematic literature search and with the participation of all professional societies and associations involved in the management of the disease. Part 2 addresses issues such as proper risk stratification, the various therapeutic approaches, and prevention as well as follow-up of patients with basal cell carcinoma.
Keywords
Aged Aged, 80 and over Basal Cell Carcinoma/epidemiology/*pathology/prevention & control/therapy Disease Management Follow-Up Studies Germany/epidemiology Humans Incidence Managed Care Programs/*standards Middle Aged Neoplasm Recurrence, Local/epidemiology/pathology/prevention & control Practice Guidelines as Topic Quality of Health Care/*standards Risk Assessment Skin Neoplasms/epidemiology/*pathology/therapy